209 related articles for article (PubMed ID: 22484184)
1. Advances in the chemoprevention of non-melanoma skin cancer in high-risk organ transplant recipients.
Lien MH; Fenske NA; Glass LF
Semin Oncol; 2012 Apr; 39(2):134-8. PubMed ID: 22484184
[TBL] [Abstract][Full Text] [Related]
2. Systemic strategies for chemoprevention of skin cancers in transplant recipients.
Kovach BT; Sams HH; Stasko T
Clin Transplant; 2005 Dec; 19(6):726-34. PubMed ID: 16313317
[TBL] [Abstract][Full Text] [Related]
3. Systemic retinoids: chemoprevention of skin cancer in transplant recipients.
Hardin J; Mydlarski PR
Skin Therapy Lett; 2010; 15(7):1-4. PubMed ID: 20700551
[TBL] [Abstract][Full Text] [Related]
4. Oral retinoids for chemoprevention of skin cancers in organ transplant recipients: results of a survey.
Kovach BT; Murphy G; Otley CC; Shumack S; Ulrich C; Stasko T
Transplant Proc; 2006 Jun; 38(5):1366-8. PubMed ID: 16797305
[TBL] [Abstract][Full Text] [Related]
5. Practical retinoid chemoprophylaxis in solid organ transplant recipients.
Neuhaus IM; Tope WD
Dermatol Ther; 2005; 18(1):28-33. PubMed ID: 15842610
[TBL] [Abstract][Full Text] [Related]
6. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients.
De Graaf YG; Euvrard S; Bouwes Bavinck JN
Dermatol Surg; 2004 Apr; 30(4 Pt 2):656-61. PubMed ID: 15061851
[TBL] [Abstract][Full Text] [Related]
7. Retinoid chemoprevention in patients at high risk for skin cancer.
DiGiovanna JJ
Med Pediatr Oncol; 2001 May; 36(5):564-7. PubMed ID: 11340613
[TBL] [Abstract][Full Text] [Related]
8. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.
Harwood CA; Leedham-Green M; Leigh IM; Proby CM
Arch Dermatol; 2005 Apr; 141(4):456-64. PubMed ID: 15837863
[TBL] [Abstract][Full Text] [Related]
9. [Skin cancer and other skin disorders in patients following solid organ transplantation].
de Graaf YG; de Fijter JW; Posma AN; Feltkamp MC; Claas FH; Bouwes Bavinck JN
Ned Tijdschr Geneeskd; 2005 Mar; 149(10):511-7. PubMed ID: 15782685
[TBL] [Abstract][Full Text] [Related]
10. Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients.
Alter M; Satzger I; Schrem H; Kaltenborn A; Kapp A; Gutzmer R
J Dtsch Dermatol Ges; 2014 Jun; 12(6):480-8. PubMed ID: 24813579
[TBL] [Abstract][Full Text] [Related]
11. Skin cancer chemoprevention with systemic retinoids: an adjunct in the management of selected high-risk patients.
Campbell RM; DiGiovanna JJ
Dermatol Ther; 2006; 19(5):306-14. PubMed ID: 17014486
[TBL] [Abstract][Full Text] [Related]
12. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials.
Chen K; Craig JC; Shumack S
Br J Dermatol; 2005 Mar; 152(3):518-23. PubMed ID: 15787821
[TBL] [Abstract][Full Text] [Related]
13. Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy.
Gibson GE; O'Grady A; Kay EW; Leader M; Murphy GM
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):130-6. PubMed ID: 9553909
[TBL] [Abstract][Full Text] [Related]
14. Reducing skin malignancy risk in organ transplant recipients.
Francis S; Berg D
Skin Therapy Lett; 2013 Jan; 18(1):1-3. PubMed ID: 23474655
[TBL] [Abstract][Full Text] [Related]
15. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
[TBL] [Abstract][Full Text] [Related]
16. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
Levine N; Moon TE; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):957-61. PubMed ID: 9367070
[TBL] [Abstract][Full Text] [Related]
17. Overview on non-melanoma skin cancers in solid organ transplant recipients.
Forchetti G; Suppa M; Del Marmol V
G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224
[TBL] [Abstract][Full Text] [Related]
18. Systemic retinoids for chemoprevention of non-melanoma skin cancer in high-risk patients.
Marquez C; Bair SM; Smithberger E; Cherpelis BS; Glass LF
J Drugs Dermatol; 2010 Jul; 9(7):753-8. PubMed ID: 20677528
[TBL] [Abstract][Full Text] [Related]
19. Complications of systemic retinoid therapy in organ transplant recipients with squamous cell carcinoma.
Martinez JC; Otley CC; Euvrard S; Arpey CJ; Stasko T;
Dermatol Surg; 2004 Apr; 30(4 Pt 2):662-6. PubMed ID: 15061852
[TBL] [Abstract][Full Text] [Related]
20. Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer.
Nemer KM; Council ML
Dermatol Clin; 2019 Jul; 37(3):287-295. PubMed ID: 31084723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
